- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CNS Malignancy in New Zealand
Total 1285 results
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
Zealand University HospitalCompletedChronic Pain | Non-malignant PainDenmark
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterCivaTech OncologyActive, not recruitingAbdominal Malignancy | Pelvic MalignancyUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Memorial Sloan Kettering Cancer CenterColumbia University; University of Wisconsin, Madison; Keryx Biopharmaceuticals; Keryx / AOI Pharmaceuticals, Inc... and other collaboratorsCompletedCancer | Brain Cancer | Malignant Gliomas | CNSUnited States
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
Aprea TherapeuticsCompletedMyeloid MalignancyUnited States
-
Columbia UniversityNational Multiple Sclerosis Society; Exegi PharmaRecruitingMultiple Sclerosis | Clinically Isolated Syndrome (CIS)United States
-
Martin GutierrezHackensack Meridian Health; Karyopharm Therapeutics IncWithdrawn
-
Reveal Pharmaceuticals Inc.National Cancer Institute (NCI)RecruitingCentral Nervous System (CNS) LesionsUnited States
-
Memorial Sloan Kettering Cancer CenterRockefeller UniversityCompletedPrimary or Metastatic Central Nervous System (CNS) TumorUnited States
-
Dr David ZieglerEngeneic Pty LimitedTerminatedSolid Tumours | CNS TumoursAustralia
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Arbor Pharmaceuticals, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; Northwestern University; University of Calgary; Schering-Ploug... and other collaboratorsCompletedCNS Cancer | CNS BRAINUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
Astellas Pharma Global Development, Inc.CompletedRelapsed Lymphoid Malignancy | Refractory Lymphoid MalignancyUnited States, Canada
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
All India Institute of Medical Sciences, New DelhiUnknownUltrasonography | Gastrointestinal Disease | MalignancyIndia
-
GB005, Inc., a wholly owned subsidiary of Gossamer...TerminatedCNS LymphomaUnited States, Canada, Israel, Australia, New Zealand, France
-
Memorial Sloan Kettering Cancer CenterRecruitingMalignant Solid TumorsUnited States
-
Eisai Inc.CompletedCancer, Malignant TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Solid MalignancyUnited States
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
-
Memorial Sloan Kettering Cancer CenterCompletedNon-Hodgkin's Lymphoma | CNS Lymphoma | CNS Brain CancerUnited States
-
Bristol-Myers SquibbTerminatedCancer | Neoplasm | Tumors | MalignancyUnited States, Canada, Spain, Switzerland
-
Incyte CorporationTerminatedSolid Tumor MalignancyUnited States, France, United Kingdom, Italy, Korea, Republic of, Japan, Spain, Israel, Denmark, Germany, Switzerland
-
Memorial Sloan Kettering Cancer CenterMillennium: The Takeda Oncology CompanyCompletedMyeloid Hematologic Malignancy | Lymphoid Hematologic MalignancyUnited States
-
NYU Langone HealthActive, not recruitingHematologic MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
New Mexico Cancer Care AllianceNational Cancer Institute (NCI)RecruitingMalignant NeoplasmUnited States
-
Roswell Park Cancer InstituteTerminatedMalignant NeoplasmUnited States
-
All India Institute of Medical Sciences, New DelhiCompletedMalignant Childhood NeoplasmIndia
-
Australian & New Zealand Children's Haematology...National Health and Medical Research Council, Australia; Secura Bio, Inc.TerminatedRhabdoid Tumor | Atypical Teratoid/Rhabdoid Tumor | Malignant Rhabdoid Tumor | Recurrent Brain Tumor, ChildhoodAustralia, New Zealand, United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); University of Pennsylvania; RTI International; ITX CorporationCompletedMelanoma and Other Malignant Neoplasms of SkinUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyRecruitingMalignant NeoplasmUnited States
-
Hoffmann-La RocheRecruitingALK Fusion-positive Solid or CNS TumorsUnited States, Korea, Republic of, China, Spain, Canada, United Kingdom, Australia, Denmark, France, Italy, Germany
-
National Cancer Institute (NCI)Active, not recruitingUnresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Tulane UniversityAmerican Cancer Society, Inc.; University Medical Center-New OrleansRecruitingCancer | Neoplasm MalignantUnited States
-
Eli Lilly and CompanyCompletedMalignant Solid TumorUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingMalignancyUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Liver | Unresectable Solid NeoplasmUnited States, Canada
-
Eli Lilly and CompanyCompletedMalignant Solid TumorUnited States